肺部恶性肿瘤切除中肺动脉切除的临床选择与结局
该研究回顾2000至2018年间9位外科医生实施的34例肺动脉切除(用于原发或转移性肺部恶性肿瘤),排除3例侧壁钉合切除和3例转移瘤切除后分析生存。
要点
- 肺动脉切除重建可安全用于侵犯主肺动脉的中央型肺癌,避免全肺切除。
- 支气管袖状联合肺动脉成形者无病5年生存50%,优于单纯肺动脉成形19%。
- 复发以远处转移为主,强调全身治疗的重要性。
核心结论
- 对于恶性肺疾病,肺动脉切除与重建可安全实施,在全肺切除候选者中手术风险低。
- 长期生存受损主要源于远处复发而非局部复发,凸显全身治疗的重要性。
研究设计与样本
- 回顾性队列研究,纳入2000至2018年9位外科医生实施的34例肺动脉切除(原发或转移性肺部恶性肿瘤)。
- 排除侧壁钉合肺动脉切除3例和转移瘤切除3例后行生存分析。
- 独立判断全肺切除候选资格和动脉成形技术。
主要发现
- 肺动脉切除方式包括袖状切除一期吻合(14.7%)、非环周切除一期闭合(61.8%)、钉合闭合(8.8%)和补片闭合(14.7%)。
- 动脉切除占每位外科医生全肺切除量的2.5%至43%。
- 无手术死亡,术后47天死亡1例;术后并发症21例(61.8%);无患者需补充全肺切除。
- 总5年生存率33%(95%CI 12-53)。
临床怎么用
- 对侵犯主肺动脉的中央型肺癌,可考虑肺动脉切除重建以替代全肺切除。
- 支气管袖状联合肺动脉成形可能改善无病生存和降低复发,可优先考虑。
- 术后应重视全身治疗以控制远处转移。
局限性
- 样本量小(34例),生存分析排除6例后样本更少。
- 回顾性设计,存在选择偏倚。
- 单机构经验,不同外科医生技术异质性大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complete resection of central tumors invading the main pulmonary artery (PA) requires arterial reconstruction to avoid pneumonectomy. Oncologic equivalence with pneumonectomy has been suggested. We review clinical selection and outcome for these uncommon procedures in the context of candidacy for pneumonectomy. METHODS: From 2000 to 2018, 9 different surgeons performed 34 pulmonary arterial resections for primary or metastatic pulmonary malignancy, with independent determination of pneumonectomy candidacy and arterioplasty technique. Patients undergoing limited lateral stapled PA resection (n = 3) or resection for metastasis (n = 3) were excluded from survival analysis. RESULTS: The PA was resected as a sleeve with primary anastomosis (14.7%) or noncircumferentially with primary (61.8%), stapled (8.8%), or patch (14.7%) closure. Arterial resections represented between 2.5% and 43% of each surgeon's pneumonectomy volume. Sixteen (47%) patients were candidates for pneumonectomy. There was no operative mortality and 1 death at 47 days. Postoperative complications occurred in 21 (61.8%) patients. No patient required completion pneumonectomy. Overall 5-year survival was 33% (95% confidence interval [CI], 12-53). Compared with pulmonary arterioplasty alone, patients undergoing bronchial sleeve resection and pulmonary arterioplasty had better disease-free 5-year survival (50% [95% CI, 18-82] vs 19% [95% CI, 5-43]; P = .04), higher complete resection rate (100% [95% CI, 83-100] vs 80% [95% CI, 56-94]; P = .23) and lower disease recurrence (8% [n = 1 of 13] vs 47% [n = 7 of 15]; P = .04); 80% of disease recurrence was distant. CONCLUSIONS: Resection and reconstruction of the PA for malignant lung disease may be safely performed. In candidates for pneumonectomy, arterial resection offers low operative risk. Long-term survival is impaired by distant, not local, recurrence emphasizing the importance of systemic therapy.
引用
- Madariaga MLL, Geller A, Lanuti M, et al. Pulmonary Artery Resection During Lung Resection for Malignancy. Ann Thorac Surg. 2019. PMID: 31336066. doi:10.1016/j.athoracsur.2019.05.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。